Limited Liability Company (LLC)
Sciencepharma
Sciencepharma Spółka z Ograniczoną Odpowiedzialnością
Limited Liability Company (LLC)
Sciencepharma Spółka z Ograniczoną Odpowiedzialnością
Sciencepharma compared with its industry and competitors: revenue, profit and capital percentiles. Regional ranking and position within its PKD class.
Comparison with PKD sector 21.20.Z
Comparison with selected competing entities based on the most important financial indicators from recent years.
Type a name or KRS number to add any company to the chart and table below. Compared: 6 (5 competitors + analysed).
Indicator: Revenue
One chart shows the analysed company alongside selected competitors. The view presents the most important financial indicators from recent years, letting you quickly assess scale, profitability and the company's market position.
A side-by-side comparison of the most important financial data for the analysed company and its peers.
| Company | Revenue▼ | Net profit | EBITDA | Assets | Equity | Net margin | ROE | Liquidity | Years | Latest year | |
|---|---|---|---|---|---|---|---|---|---|---|---|
SciencepharmaAnalysed WARSZAWA · Farmaceutyka | 443,7 mln zł | 122,1 tys. zł | -909,6 tys. zł | 292,5 mln zł | 44,8 mln zł | 0,03% | 0,27% | 1,20 | 5 | 2025 | |
GEDEON RICHTER POLSKA GRODZISK MAZOWIECKI · Farmaceutyka | 387,2 mln zł | 3,0 mln zł | - | 413,6 mln zł | 231,9 mln zł | 0,79% | 1,31% | 3,33 | 3 | 2024 | |
NATUR PRODUKT PHARMA OSTRÓW MAZOWIECKA · Farmaceutyka | 369,5 mln zł | 53,6 mln zł | 72,2 mln zł | 252,6 mln zł | 227,5 mln zł | 14,51% | 23,57% | 9,64 | 3 | 2025 | |
PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEK-AM ZAKROCZYM · Farmaceutyka | 353,4 mln zł | 40,8 mln zł | 75,6 mln zł | 374,6 mln zł | 185,6 mln zł | 11,55% | 21,99% | 1,50 | 2 | 2024 | |
KRKA-POLSKA WARSZAWA · Farmaceutyka | 347,2 mln zł | 18,4 mln zł | 34,1 mln zł | 229,6 mln zł | 123,9 mln zł | 5,29% | 14,82% | 1,88 | 8 | 2025 | |
SYNOPTIS PHARMA WARSZAWA · Farmaceutyka | 314,2 mln zł | 54,1 mln zł | 71,0 mln zł | 134,4 mln zł | 72,1 mln zł | 17,21% | 75,03% | 1,79 | 8 | 2025 |
Each row is a different financial indicator. The arrow and percentage value show how much each competitor exceeds or trails the analysed company.Green means the analysed company leads, red - that it falls behind.
| Indicator | Sciencepharma 2025 | GEDEON RICHTER POLSKA 2024 | NATUR PRODUKT PHARMA 2025 | PRZEDSIĘBIORSTWO FARMACEUTY… 2024 | KRKA-POLSKA 2025 | SYNOPTIS PHARMA 2025 |
|---|---|---|---|---|---|---|
| Revenue | 443,7 mln zł | 387,2 mln zł -12.7% | 369,5 mln zł -16.7% | 353,4 mln zł -20.3% | 347,2 mln zł -21.8% | 314,2 mln zł -29.2% |
| Net profit | 122,1 tys. zł | 3,0 mln zł +2392.2% | 53,6 mln zł +43797.2% | 40,8 mln zł +33318.0% | 18,4 mln zł +14936.2% | 54,1 mln zł +44178.9% |
| EBITDA | -909,6 tys. zł | - | 72,2 mln zł +8042.9% | 75,6 mln zł +8407.1% | 34,1 mln zł +3848.8% | 71,0 mln zł +7904.2% |
| Operating profit | -986,0 tys. zł | 86,4 mln zł +8866.9% | 64,5 mln zł +6641.9% | 57,4 mln zł +5918.3% | 23,5 mln zł +2478.8% | 69,5 mln zł +7150.2% |
| Assets | 292,5 mln zł | 413,6 mln zł +41.4% | 252,6 mln zł -13.6% | 374,6 mln zł +28.1% | 229,6 mln zł -21.5% | 134,4 mln zł -54.1% |
| Equity | 44,8 mln zł | 231,9 mln zł +417.4% | 227,5 mln zł +407.5% | 185,6 mln zł +314.1% | 123,9 mln zł +176.4% | 72,1 mln zł +60.8% |
| Net margin | 0,03% | 0,79% +0.8 pp | 14,51% +14.5 pp | 11,55% +11.5 pp | 5,29% +5.3 pp | 17,21% +17.2 pp |
| ROE | 0,27% | 1,31% +1.0 pp | 23,57% +23.3 pp | 21,99% +21.7 pp | 14,82% +14.6 pp | 75,03% +74.8 pp |
| Current ratio | 1,20 | 3,33 +212.7 pp | 9,64 +844.3 pp | 1,50 +30.1 pp | 1,88 +68.1 pp | 1,79 +59.5 pp |
Peer entities are picked based on activity profile (PKD), voivodeship, business scale and data availability. You can add your own peers using the search above.
Filter: PKD 21.20.Z, voivodeship mazowieckie. Data taken from /ranking and /reports.
PKD 21.20.Z - MAZOWIECKIE
Voivodeship
MAZOWIECKIE
94 companies in PKD in this voivodeship
Companies in PKD - voivodeship
94
Companies in PKD - nationwide
287
Voivodeship share of PKD
32.75%
Revenue position
2 / 94
Avg. PKD revenue (region)
39.3 M PLN
Median PKD revenue (region)
1.9 M PLN